Current Affairs   »   Alphabet Inc launches AI-driven drug discovery...

Alphabet Inc launches AI-driven drug discovery start-up Isomorphic Labs

Alphabet Inc launches AI-driven drug discovery start-up Isomorphic Labs_50.1

Google parent company Alphabet Inc. has launched a new company in London called Isomorphic Labs. The company aims to use AI (artificial intelligence) for drug discovery and medicine to find cures for some of humanity’s most devastating diseases. Demis Hassabis will be the CEO of Isomorphic Labs. Hassabis is the CEO and co-founder of DeepMind, another Alphabet subsidiary that used AI to predict the 3D structure of a protein directly from its amino acid sequence.

Buy Prime Test Series for all Banking, SSC, Insurance & other exams

The London-based Isomorphic Labs will work on the most important applications of AI — in the field of biological and medical research. The company aims to use AI to accelerate drug discovery, and ultimately, find cures for some of humanity’s most devastating diseases. The new venture also plans to partner with biomedical and pharmaceutical companies, using artificial intelligence to discover new medicinal advancements.

Important takeaways for all competitive exams:

  • Google CEO: Sundar Pichai.
  • Google Founded: 4 September 1998, California, United States.
  • Google Founders: Larry Page, Sergey Brin.

Find More Sci-Tech News Here

Alphabet Inc launches AI-driven drug discovery start-up Isomorphic Labs_60.1

Alphabet Inc launches AI-driven drug discovery start-up Isomorphic Labs_70.1

Thank You, Your details have been submitted we will get back to you.
Was this page helpful?

Leave a comment

Your email address will not be published. Required fields are marked *